David Sillence

Last updated

David Owen Sillence
Born1944 (age 8081)
Alma mater University of Sydney; University of Melbourne
Known forClassification of osteogenesis imperfecta
Founding clinical genetics in the Asia-Pacific
Scientific career
Fields Medical Genetics
Institutions University of Sydney; The Children's Hospital at Westmead
Website www.sydney.edu.au/medicine-health/about/our-people/academic-staff/david-sillence.html

David Owen Sillence [1] AM (born 1944) is an academic and medical geneticist. He is an emeritus professor at the University of Sydney, where he was the foundation chair (Professor) of Medical Genetics.

Contents

Early life and education

Sillence was born and raised in Australia. He received his bachelor of medicine from the University of Sydney in 1970 [2] and an MD in medical genetics from the University of Melbourne in 1978.[ citation needed ]

Career

In 1984, Sillence became the Foundation Head of the Department of Clinical Genetics at the Royal Alexandra Hospital. [3]

He was the Foundation Professor of Medical Genetics at the University of Sydney in 1988 and the Foundation Head, Discipline of Genetic Medicine in 2005. [4]

He was part of the committee that pioneered the measurement of bone density in children in Australia and the team that pioneered the systematic treatment of osteoporosis in Osteogenesis Imperfects in children in Australia. [5]

Sillence was a founding member of the Human Genetics Society of Australasia (1978), the Australian Teratology Society (1981), the Australian Faculty of Public Health Medicine (1990), and the American College of Medical Genetics (1993) and has held office in the Human Genetics Society of Australasia from 1981 to 2000, often with more than one concurrent position. He has also held office in the Royal Australasian College of Physicians from 1994 to 2000. He has been a member of many committees within the School of Public Health and Tropical Medicine, and the University of Sydney. He currently serves on the International Nomenclature Committee for Constitutional Disorders of the Skeleton, the International mucopolysaccharidosis type I expert committee, the National Fabry Disease and MPS expert committees for the LSDP.[ citation needed ]

Sillence was instrumental in establishing the first working party to write guidelines for training in Clinical Genetics in Australia and was granted Clinical Geneticist status (1987) through the grandfather clause. This certification model has been used by other Special Interest Groups within the Human Genetics Society of Australasia. He has been involved in a considerable amount of collaborative research as well as those within his department. He has published over 130 original articles, has contributed over 30 book chapters, 8 books/monographs, and has contributed to conference proceedings more than a dozen times. He has been a peer reviewer/editor to 8 different groups/journals. [6]

Sillence created the standard four-type system of osteogenesis imperfecta in 1979. [7] It enabled progress into the molecular causes of the disorder and collagen mutations.

In 2012, Sillence delivered the Human Genetics Society of Australasia Oration, a prestigious lecture in his field. [8]

Sillence was appointed a Member of the Order of Australia (AM) in the 2013 Australia Day Honours. [9]

Related Research Articles

<span class="mw-page-title-main">Osteogenesis imperfecta</span> Group of genetic disorders resulting in fragile bones

Osteogenesis imperfecta, colloquially known as brittle bone disease, is a group of genetic disorders that all result in bones that break easily. The range of symptoms—on the skeleton as well as on the body's other organs—may be mild to severe. Symptoms found in various types of OI include whites of the eye (sclerae) that are blue instead, short stature, loose joints, hearing loss, breathing problems and problems with the teeth. Potentially life-threatening complications, all of which become more common in more severe OI, include: tearing (dissection) of the major arteries, such as the aorta; pulmonary valve insufficiency secondary to distortion of the ribcage; and basilar invagination.

<span class="mw-page-title-main">Dragan Primorac</span> Croatian physician and geneticist

Dragan Primorac is a Croatian politician, physician, geneticist, and forensic scientist. He served as Minister of Science, Education and Sports in the 9th and 10th government of Croatia under HDZ's Ivo Sanader, and was a presidential candidate in the 2009 and 2024 elections.

An osteochondrodysplasia, or skeletal dysplasia, is a disorder of the development of bone and cartilage. Osteochondrodysplasias are rare diseases. About 1 in 5,000 babies are born with some type of skeletal dysplasia. Nonetheless, if taken collectively, genetic skeletal dysplasias or osteochondrodysplasias comprise a recognizable group of genetically determined disorders with generalized skeletal affection. These disorders lead to disproportionate short stature and bone abnormalities, particularly in the arms, legs, and spine. Skeletal dysplasia can result in marked functional limitation and even mortality.

<span class="mw-page-title-main">Jonathan Simons</span> American oncologist

Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the medical director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.

<span class="mw-page-title-main">Bruce R. Korf</span> American geneticist

Bruce Richard Korf is a medical geneticist at the University of Alabama at Birmingham. In April 2009, he began a two-year term as president of the American College of Medical Genetics (ACMG), a professional organization.

<span class="mw-page-title-main">David S Rosenblatt</span> Canadian medical geneticist and pediatrician

David Rosenblatt is a Canadian medical geneticist, pediatrician, and professor in the departments of Human Genetics, Medicine, Pediatrics, and Biology at McGill University in Montreal, Quebec, where he was the chairman of the Department of Human Genetics from 2001 to 2013. He is known for his contributions to the field of inborn errors of folate and vitamin B12 metabolism.

Kathryn Nance North is a paediatric physician, neurologist, and clinical geneticist. In 2013, she was appointed Director of the Murdoch Children's Research Institute and was named the David Danks Professor of Child Health Research at the University of Melbourne. In 2012, North was appointed chair of the National Health and Medical Research Council Research Committee. In 2014, she was appointed vice chair of the Global Alliance for Genomics and Health (GA4GH) and co-chair of its Clinical Working Group.

<span class="mw-page-title-main">Katherine Belov</span> Australian geneticist

Katherine Belov is an Australian geneticist, professor of comparative genomics in the School of Life and Environmental Sciences and Pro Vice Chancellor of Global Engagement at the University of Sydney. She is head of the Australasian Wildlife Genomics Group and research expert in the area of comparative genomics and immunogenetics, including Tasmanian devils and koalas, two iconic Australian species that are threatened by disease processes. Throughout her career, she has disproved the idea that marsupial immune system is primitive, characterized the South American gray short-tailed opossum's immune genes, participated in the Platypus Genome Project, led research identifying the properties of platypus venom, and identified the cause of the spread of the Tasmanian devil's contagious cancer.

<span class="mw-page-title-main">John M. Opitz</span> German-American geneticist (1935–2023)

John M. Opitz was a German-American medical geneticist and professor at the University of Utah School of Medicine. He is best known for rediscovering the concept of the developmental field in humans and for his detection and delineation of many genetic syndromes, several now known as the "Opitz syndromes" including Smith–Lemli–Opitz syndrome (SLOS), Opitz–Kaveggia syndrome (FGS1), Opitz G/BBB syndrome, Bohring–Opitz syndrome, and other autosomal and X-linked conditions. He is founder of the Wisconsin Clinical Genetics Center, the American Journal of Medical Genetics, and was a cofounder of the American College and American Board of Medical Genetics.

David Albert Cooper was an Australian HIV/AIDS researcher, immunologist, professor at the University of New South Wales, and the director of the Kirby Institute. He and Professor Ron Penny diagnosed the first case of HIV in Australia.

David Joshua Handelsman, (AO) is trained in Medicine and Endocrinology. His expertise is in testicular function and androgen physiology, pharmacology, and toxicology. His experience spans basic, clinical, and public health domains including a recent focus on genetic models of androgen action, steroid mass spectrometry, and anti-doping science. He was Australia's first Professor in Reproductive Endocrinology and Andrology. He has worked in the US, Australia, and Germany. His professional involvement includes the World Health Organization (WHO) Human Reproduction Programme's Male Task Force, the United Nations Fund for Population Activities, Endocrine Society of Australia, World Anti-Doping Agency's Health, Medicine and Research Committee, and Australian Drug Evaluation Committee.

Leon Emanuel Rosenberg was an American physician-scientist, geneticist, and educator. He served as chair of the department of human genetics and also as dean of the medical school of Yale University. He then worked as the chief scientific officer of the Bristol-Myers Squibb Pharmaceutical company. He wrote more than 300 research articles, chapters, and books on his scientific research and public policy views across his career.

Bettina Meiser is a professor at the University of New South Wales, with expertise in the psychosocial aspects of genetics; cancer, hereditary cancer, and the impact of genetic counselling and testing.

The Human Genetics Society of Australasia (HGSA) is a membership organization for individuals in the field of human genetics who primarily practise in the Oceania region. Members typically hold both a qualification in human genetics and work in the field. Membership is drawn from clinical, laboratory and academic specialties. Members include clinical geneticists; genetic counsellors; laboratory scientists ; and academics.

<span class="mw-page-title-main">Grant Robert Sutherland</span> Australian geneticist (born 1945)

Grant Robert Sutherland is a retired Australian human geneticist and cytogeneticist. He was the Director, Department of Cytogenetics and Molecular Genetics, Adelaide Women's and Children's Hospital for 27 years (1975-2002), then became the Foundation Research Fellow there until 2007. He is an Emeritus Professor in the Departments of Paediatrics and Genetics at the University of Adelaide.

John Christodoulou is an Australian medical geneticist, genetic pathologist and clinical scientist. He is director of the Genetics Theme and Group Co-Leader of the Brain and Mitochondrial Research Group at Murdoch Children's Research Institute. Additionally, he holds the Chair in Genomic Medicine, Department of Paediatrics, The University of Melbourne.

Elaine H. Zackai is a Professor of Pediatrics, Director of Clinical Genetics, and the Director of the Clinical Genetics Center at Children's Hospital of Philadelphia (CHOP).

Robert John Walsh was an Australian medical scientist and geneticist. He set up the New South Wales Red Cross Blood Transfusion Service, serving as its inaugural Director for twenty years from 1946 to 1966. From 1973 to 1982, he was the Dean of the Faculty of Medicine at the University of New South Wales. His research activities covered a wide range, including iron metabolism, blood groups, genetic influences on diseases, and improving techniques and equipment for collecting, processing, and transporting blood and its products. In 1982 he was awarded Australia's highest civilian honour, Companion of the Order of Australia, for his services to medicine.

Pisit Pitukcheewanont, also known as "Dr. Duke" is a Doctor of Medicine, a former professor of Clinical Pediatrics and a philanthropist. Currently, he is an adjunct professor of Clinical Pediatrics at Keck School of Medicine of the University of Southern California, the president of a nonprofit organization, The Human Growth Foundation and Senior Vice President of Global Clinical Development and Medical Affairs Lumos Pharmacy.

<span class="mw-page-title-main">John Hemsley Pearn</span> Australian paediatrician

John Hemsley Pearn is a retired Australian paediatrician, soldier, former surgeon general of the Australian Defence Force, academic, historian, author, educator, and polymath.

References

  1. Mellor L (2008). "Sillence, David Owen". Faculty of Medicine Online Museum and Archive. University of Sydney. Archived from the original on 19 July 2016. Retrieved 16 August 2021.
  2. "- Our people - Sydney Medical School - The University of Sydney". www.sydney.edu.au. Retrieved 24 December 2024.
  3. "Sillence, David Owen - Faculty of Medicine Online Museum and Archive". www.sydney.edu.au. Retrieved 9 January 2025.
  4. "Sillence, David Owen - Faculty of Medicine Online Museum and Archive". www.sydney.edu.au. Retrieved 18 January 2025.
  5. "Sillence, David Owen - Faculty of Medicine Online Museum and Archive". www.sydney.edu.au. Retrieved 23 January 2025.
  6. "David Sillence". BiomedExperts. Archived from the original on 16 July 2011. Retrieved 25 August 2009.
  7. Sillence DO, Senn A, Danks DM (April 1979). "Genetic heterogeneity in osteogenesis imperfecta". Journal of Medical Genetics. 16 (2): 101–16. doi:10.1136/jmg.16.2.101. PMC   1012733 . PMID   458828.
  8. Sutherland GR (2008). "The history and development of the Human Genetics Society of Australasia" (PDF). Twin Research and Human Genetics. 11 (4). Adelaide: Department of Genetics, Women's and Children's Hospital: 363–367. doi:10.1375/twin.11.4.363. PMID   18637737. S2CID   32531881. Archived from the original (PDF) on 18 March 2012. Retrieved 26 August 2012.
  9. "Professor David Owen SILLENCE". Australian Honours Search Facility. Retrieved 10 October 2024.